In RA models with GR deleted in myeloid cells, dendritic cells, B cells, or T cells, only T-cell-specific GR deletion attenuated the therapeutic benefit of glucocorticoids, indicating that T-cell-intrinsic GR signaling is necessary for anti-inflammatory efficacy.721. Here, NR3C1 is linked to rheumatoid arthritis.